NO992502D0 - 2-Imidazolinylaminoindazole compounds useful as <alfa> -2 adrenergic receptor agonists - Google Patents

2-Imidazolinylaminoindazole compounds useful as <alfa> -2 adrenergic receptor agonists

Info

Publication number
NO992502D0
NO992502D0 NO992502A NO992502A NO992502D0 NO 992502 D0 NO992502 D0 NO 992502D0 NO 992502 A NO992502 A NO 992502A NO 992502 A NO992502 A NO 992502A NO 992502 D0 NO992502 D0 NO 992502D0
Authority
NO
Norway
Prior art keywords
imidazolinylaminoindazole
alfa
receptor agonists
adrenergic receptor
compounds useful
Prior art date
Application number
NO992502A
Other languages
Norwegian (no)
Other versions
NO992502L (en
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Jeffrey Joseph Ares
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992502D0 publication Critical patent/NO992502D0/en
Publication of NO992502L publication Critical patent/NO992502L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
NO992502A 1996-11-25 1999-05-25 2-Imidazolinylaminoindazole compounds useful as <alfa> -2 adrenergic receptor agonists NO992502L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25
PCT/US1997/020551 WO1998023609A1 (en) 1996-11-25 1997-11-21 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists

Publications (2)

Publication Number Publication Date
NO992502D0 true NO992502D0 (en) 1999-05-25
NO992502L NO992502L (en) 1999-07-26

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992502A NO992502L (en) 1996-11-25 1999-05-25 2-Imidazolinylaminoindazole compounds useful as <alfa> -2 adrenergic receptor agonists

Country Status (20)

Country Link
EP (1) EP0944620A1 (en)
JP (1) JP2001506599A (en)
KR (1) KR20000069104A (en)
CN (1) CN1244864A (en)
AR (1) AR010643A1 (en)
AU (1) AU5433998A (en)
BR (1) BR9713535A (en)
CA (1) CA2272644A1 (en)
CO (1) CO4910166A1 (en)
CZ (1) CZ183999A3 (en)
HU (1) HUP9904660A3 (en)
ID (1) ID22676A (en)
IL (1) IL130067A0 (en)
NO (1) NO992502L (en)
NZ (1) NZ335882A (en)
PE (1) PE47099A1 (en)
SK (1) SK69699A3 (en)
TR (1) TR199901542T2 (en)
WO (1) WO1998023609A1 (en)
ZA (1) ZA9710576B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
EP2226315A4 (en) 2007-12-28 2012-01-25 Carna Biosciences Inc 2-aminoquinazoline derivative
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (en) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 Preparation method of debrominated impurities of brimonidine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
BR9408342A (en) * 1993-12-17 1997-08-19 Procter & Gamble 6- (2-imidazolinylamino) quinoxaline compounds useful as alpha-2 adrenoceptor agonists
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
CZ183999A3 (en) 1999-11-17
EP0944620A1 (en) 1999-09-29
IL130067A0 (en) 2000-02-29
PE47099A1 (en) 1999-06-12
KR20000069104A (en) 2000-11-25
JP2001506599A (en) 2001-05-22
CA2272644A1 (en) 1998-06-04
NO992502L (en) 1999-07-26
HUP9904660A2 (en) 2000-06-28
CO4910166A1 (en) 2000-04-24
AU5433998A (en) 1998-06-22
TR199901542T2 (en) 2000-01-21
WO1998023609A1 (en) 1998-06-04
CN1244864A (en) 2000-02-16
ZA9710576B (en) 1998-09-16
HUP9904660A3 (en) 2002-02-28
AR010643A1 (en) 2000-06-28
ID22676A (en) 1999-12-09
NZ335882A (en) 2000-12-22
SK69699A3 (en) 2000-06-12
BR9713535A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
NO20010603D0 (en) 2-substituted-1-piperidylbenzimidazole compounds as ORL 1 receptor agonists
NO992470L (en) 2-amidazolinyl-amino-indole compounds useful as &lt;alpha&gt; -2-adrenoceptor agonists
NO20001141D0 (en) Aromatic C16-C20 substituted tetrahydro-prostaglandins useful as FP agonists
NO20001139L (en) Aromatic C16-C20 substituted tetrahydro-prostaglandins useful as FP agonists
NO20001142D0 (en) Aromatic C16-C20 substituted tetrahydro-prostaglandins useful as FP agonists
TR970073A2 (en) Pyrimidindion pyrimidintrion, triazindion, tetrahydroquinazolindion derivatives as alpha adrenergic resenter antagonists.
NO20012948L (en) Hydroxydiphenylureasulfonamides as IL-8 receptor antagonists
DK0975623T3 (en) Indazolamide compounds as sertoninergic agents
NO992498D0 (en) Guanidinyl heterocycle compounds useful as &lt;alfa&gt; -2 adrenoceptor agonists
NO983594D0 (en) Heterocyclic thioethers as additives for lubricants
NO992500D0 (en) 2-imidazolinylaminobenzoxazole compounds useful as &lt;alfa&gt; -2 adrenoceptor agonists
NO20013013L (en) &lt;Alpha&gt; v &lt;beta&gt; 6-integrin
FR2782522B1 (en) WATERPROOFING COMPOSITION
NO994106D0 (en) Oxazolidines as 5-HT 2A antagonists
NO992502D0 (en) 2-Imidazolinylaminoindazole compounds useful as &lt;alfa&gt; -2 adrenergic receptor agonists
NO20011270L (en) Tricyclic &lt;parta&gt; 3-piperidines as &lt;alfa&gt; 2 antagonists
NO992503D0 (en) Guanidinylamino heterocycle compounds useful as &lt;alfa&gt; -2 adrenergic receptor agonists
NO995030D0 (en) 5- (2-Imidazolinylamino) benzimidazole compounds useful as &lt;alpha&gt; 2-adrenoceptor agonists
FI943359A0 (en) Azacyclic-heterocyclic compounds as angiotensin II receptor antagonists
NO20012783L (en) Benzisoxazoles and phenones as &lt;alfa&gt; -2 antagonists
NO20010280D0 (en) &lt;Alfa&gt; -aminosyrefenylesterderivater
DK0929525T3 (en) Heteroberloxyethylamines as ligands of 5-HT1A receptor
SE9800458D0 (en) Novel compounds
SE9804493D0 (en) Novel compounds
SE9804494D0 (en) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application